# Correction: Antisense oligonucleotide targeting TARDBP-EGFR splicing axis inhibits progression of oral squamous cell carcinoma through ABCA1-regulated cholesterol efflux

**Authors:** Nan Ni, Moxu Wang, Zhiran Yuan, Leqi Zhang, Jilin Cai, Qingqing Du, Pengcheng Li, Chang Gao, Hanwen Zhang, Yuancheng Li, Hua Yuan

PMC · DOI: 10.1038/s41368-026-00434-7 · International Journal of Oral Science · 2026-03-04

## Full-text entities

- **Genes:** TARDBP (TAR DNA binding protein) [NCBI Gene 23435] {aka ALS10, TDP-43}, EGFR (epidermal growth factor receptor) [NCBI Gene 1956] {aka ERBB, ERBB1, ERRP, HER1, NISBD2, NNCIS}, ABCA1 (ATP binding cassette subfamily A member 1) [NCBI Gene 19] {aka ABC-1, ABC1, CERP, HDLCQTL13, HDLDT1, HPALP1}
- **Diseases:** oral squamous cell carcinoma (MESH:D000077195)
- **Chemicals:** CHX (-), cholesterol (MESH:D002784), MG132 (MESH:C072553)
- **Cell lines:** HN6 — Homo sapiens (Human), Tongue squamous cell carcinoma, Cancer cell line (CVCL_8129), CAL27 — Homo sapiens (Human), Tongue adenosquamous carcinoma, Cancer cell line (CVCL_1107)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12957366/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12957366/full.md

---
Source: https://tomesphere.com/paper/PMC12957366